发明公开
- 专利标题： OXAZOLIDINONES AS MODULATORS OF MGLUR5
- 专利标题（中）： 恶唑烷酮AS mGluR5调节
-
申请号： EP11785233.5申请日： 2011-11-04
-
公开(公告)号： EP2638022A1公开(公告)日： 2013-09-18
- 发明人: DEGNAN, Andrew P. , HUANG, Hong , SNYDER, Lawrence B. , YANG, Fukang , GILLMAN, Kevin W. , PARKER, Michael F.
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： Route 206 and Province Line Road Princeton, NJ 05843-4000 US
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： Route 206 and Province Line Road Princeton, NJ 05843-4000 US
- 代理机构： Reitstötter - Kinzebach
- 优先权： US412541P 20101111
- 国际公布： WO2012064603 20120518
- 主分类号： C07D263/18
- IPC分类号： C07D263/18 ; C07D413/04 ; C07D413/10 ; C07D413/14
摘要：
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, agonists and partial agonists for the mGluR5 receptor and may be useful for the treatment of various disorders of the central nervous system.
公开/授权文献
- EP2638022B1 OXAZOLIDINONES AS MODULATORS OF MGLUR5 公开/授权日：2014-12-24
信息查询
